Truelastin, Inc.
Biotechnology company developing a natural elastin dermal filler with its proprietary tissue engineering technology development platform
Truelastin, Inc. operates in biotechnology research based in Chatham, US, founded in 2010.
Profile
Our goal is to unlock the therapeutic potential of natural elastin. Our initial curiosity was ignited by studying elastin-rich mitral valve transplants. The question that emerged was simple: “Is it possible to isolate and purify elastin for a range of other applications?” The answer was YES. TruElastin has since developed and patented a novel development platform for reliably producing natural elastin biomaterials. This innovation led us to develop our first groundbreaking device candidate, a novel dermal filler that we call TEL219. It was established in Chatham, New Jersey in 2010.
Within the biotechnology research space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Chatham, US.
It is recorded at the Small private company stage.
The company reports a headcount in the 1-10 range.
| Sector | Biotechnology research |
|---|---|
| Headquarters | Chatham, US |
| Country | United States |
| Founded | 2010 |
| Employees | 1-10 |
| Stage | Small private company |
Website: truelastin.com
Browse related
Create a free account